title: Maternal-fetal HLA incompatibility and the course of inflammatory arthritis during pregnancy.
abstract: OBJECTIVE
  Studies indicate that maternal-fetal incompatibility of HLA-DR and DQ antigens may be associated with a decreased risk of disease activity during pregnancy in women with rheumatoid arthritis. We attempted to replicate these findings in a large cohort of women with inflammatory polyarthritis.
  
  
  METHODS
  Women with an inflammatory polyarthritis were recruited during the last trimester of pregnancy and were interviewed and examined in their homes by a research nurse. Each woman provided a sample of blood as well as permission for a sample of cord blood to be taken at the time of birth. DNA was extracted from both maternal and cord blood and HLA-DRB1 and DQB1 typing performed. On the basis of known haplotypes found in Caucasian populations, DQA1 type was inferred wherever possible.
  
  
  RESULTS
  Based on 110 or more maternal-fetal pairs, there was no increased occurrence of disease remission associated with maternal-fetal incompatibility of DRB1 alleles (remission ratio 0.7, 95% confidence interval 0.2-2.8), DQB1 alleles (remission ratio 1.2, 0.3-6.5), or DQA1 alleles (remission ratio 0.8,0.3-1.9). Results were similar whether maternal-fetal sharing was defined by broad allelic group or by specific alleles.
  
  
  CONCLUSIONS
  Our results do not support the hypothesis that maternal-fetal HLA incompatibility contributes to remission of inflammatory arthritis during pregnancy.
authors: Arthritis Research Campaign Epidemiology Unit, University of Manchester, UK.
authors: P
authors: P
authors: Brennan
authors: J
authors: J
authors: Barrett
authors: M
authors: M
authors: Fiddler
authors: W
authors: W
authors: Thomson
authors: T
authors: T
authors: Payton
authors: A
authors: A
authors: Silman
mesh_terms: D000328:Adult; D001172:Arthritis, Rheumatoid / Q000276:immunology* / Q000503:physiopathology; D018450:Disease Progression; D005260:Female; D005333:Fetus / Q000276:immunology*; D006683:HLA-DQ Antigens / Q000276:immunology*; D006684:HLA-DR Antigens / Q000276:immunology*; D006801:Humans; D008431:Maternal-Fetal Exchange; D011247:Pregnancy; D011248:Pregnancy Complications / Q000276:immunology* / Q000503:physiopathology
chemical_list: D006683:HLA-DQ Antigens; D006684:HLA-DR Antigens